Afuco™ Anti-Human KMA ADCC Therapeutic Antibody (MDX-1097), ADCC Enhanced

Anti-KMA ADCC Enhanced Antibody (MDX-1097) is an ADCC enhanced antibody produced by our Afuco™ platform. IST-1097 (formerly known as MDX-1097) is an antibody for liquid tumors that targets a novel B-cell surface antigen (KMA) that is specific to malignant cells. In Phase 2 clinical development.
Supplier Creative Biolabs
Product # AFC-455CL
Pricing Inquiry
Host Chimeric human/mouse
Target KMA
Species Reactivity Human
Type ADCC enhanced antibody
Storage
  • Short Term Storage: 4°C
  • Long Term Storage: -20°C
Feedback